Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, announced that the first patient has…
A new study called “MRI Biomarkers of Disease Progression in Inherited Neuropathies” received funding thanks to a grant from the National Center for Advancing Translational…
Cambridge, Mass.-based Camp4 Therapeutics announced that it has raised $45 million in Series A, led by 5AM Ventures and Northpond Ventures, alongside existing investors Andreessen…
Has Advarra established the market’s leading network of registered trial sites focusing on gene therapy studies? Put more specifically, has the commercial institutional review board (IRB)-based…
Founded in 2008, Ginkgo Bioworks is a leading American venture specializing in the growing of better products via the company’s cell programming platform, supporting a…
A novel gene therapy targeting Alzheimer’s disease will be evaluated in a Phase 1 clinical trial led by the University of California San Diego School…
Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that the Company will be presenting…
Vedere Bio II announced the completion of its $77 million Series A financing. Founded by the leadership and research team behind the former Vedere Bio,…
Recently, the National Institutes of Health (NIH) reported that an investigational gene therapy can safely restore the immune systems of infants and children who experience…
A young University of Hawaiʻi investigator pursuing novel, safer and more efficient approaches to gene therapy won a competitive National institute of Health (NIH) $2.3 million,…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
